Download the appMore options
PisaczekSearch
文AEN-US
Public health and WHOStudies updated this month

Chemotherapy: How much does it really extend life? The figures no one talks about

Sources: 10 · Article: 13 146 characters ↓

What do Natural Therapy Specialists write?

Jerzy Zięba

Analyses cited by Jerzy Zięba indicate that chemotherapy was effective in an average of less than 3% of cases.

„The scientific analyses of chemotherapy effectiveness cited in my book indicate that it was effective in an AVERAGE of less than 3% of cases. In other words, on average, chemotherapy did NOT contribute to five-year survival in 97% of cases. So what is the truth, then? A serious publication—which is, after all, entirely scientific—indicates that the cure rate after chemotherapy is very low, while Polish medical professors claim cure rates of 30 to 50%.”Cytowane w mojej książce analizy naukowe skuteczności chemioterapii wskazują, że była ona skuteczna ŚREDNIO w mniej niż 3%. Innymi słowy, średnio w 97% chemioterapia NIE przyczyniła się do przeżywalności pięcioletniej. To jak to w końcu jest? Poważna, bo przecież jak najbardziej naukowa publikacja, wskazuje na to, że wyleczalność po zastosowaniu chemioterapii jest na tak niskim poziomie, a jednocześnie polscy profesorowie medycyny twierdzą, że mają wyleczalność na poziomie 30 do 50%.
Jerzy Zięba

Jerzy Zięba claims that chemotherapy extends the life of a cancer patient by an average of 2 months.

„An analysis of these studies showed that chemotherapy does indeed extend the life of cancer patients, but by an average of… 2 months. Why is the public not told this? Why do the professors not talk about it? Why have so-called medical journalists not breathed a word about it? The lack of honesty in communicating this kind of information to the Polish public undermines the value of the professorial titles they have been awarded.”Analiza tych badań wykazała, że chemioterapia rzeczywiście przedłuża życie pacjenta nowotworowego, ale średnio o… 2 miesiące. Dlaczego nie informuje się o tym społeczeństwa? Dlaczego panowie profesorowie o tym nie mówią? Dlaczego tak zwani dziennikarze medyczni nie puścili o tym „pary z gęby?” Brak uczciwości w przekazywaniu tego typu informacji polskiemu społeczeństwu doprowadza do dewaluacji tytułów profesorskich, jakie im nadano.
Jerzy Zięba

Jerzy Zięba writes that chemotherapy causes terrible side effects in the vast majority of cases.

„It is well known that chemotherapy causes terrible side effects in the vast majority of cases. So is the price of this suffering worth paying if chemotherapy extends a patient's life by, for example, 3, 4 or 5 years?”Wiadomo, że stosowanie chemioterapii w zdecydowanej większości prowadzi do powstania fatalnych skutków ubocznych. Czy w takim razie cena tego cierpienia jest warta jego poniesienia, jeśli chemioterapia przedłuży pacjentowi życie np. o 3, 4 czy 5 lat?
Hubert Czerniak

Hubert Czerniak believes that the fight against cancer should not be based on chemotherapy; he cites a 2.1% increase in the chance of surviving five years.

„The fight against cancer does not have to be based on chemotherapy. In fact, it should not be! We may ask: Why? One answer is the results of a study published in Medical Oncology 2004, 16, 549-560. An analysis of clinical trial results from 1990–2004, covering 22 types of cancer, found that treatment with conventional chemotherapy may increase the chance of surviving five years by only 2.1%.”Walka z chorobami nowotworowymi nie musi opierać się na chemioterapii. Co więcej, nie powinna! Możemy zadać pytanie: Dlaczego? Jedna z odpowiedzi to wyniki badań opublikowanych na łamach Medical Oncology 2004, 16, 549-560. Analiza wyników badań klinicznych z lat 1990-2004 obejmujących 22 rodzaje nowotworów wykazała, że leczenie klasyczną chemioterapią może zwiększyć szansę na przeżycie 5 lat tylko o 2,1%.
Hubert Czerniak

Hubert Czerniak says that chemotherapy is completely ineffective for cancer of the uterus, prostate, skin, and kidneys, and for cancer of unknown origin.

„It is completely ineffective for cancer of the uterus, prostate, skin (melanoma), or kidneys, or for cancer of unknown origin. Despite the data above, sales of “cancer drugs” increase every year. This is a huge business in which only the patient bears the costs.”Jest całkowicie nieskuteczna w przypadku raka macicy, raka prostaty, raka skóry (melanoma), raka nerek czy raka nieznanego pochodzenia. Mimo powyższych danych, sprzedaż „leków” na nowotwory rośnie z każdym rokiem. Jest to olbrzymi biznes, w którym koszty ponosi jedynie pacjent.
Hubert Czerniak

Hubert Czerniak presents the sale of cancer drugs as a big business and suggests that companies benefit more from prolonged treatment than from a lasting cure.

„Will corporate giants take effective action against cancer? Why would they do that? After all, it is better to treat in order to keep treating than to achieve a lasting cure. The money has to add up. And how does that square with the motto of all doctors: Primum non nocere (First, do no harm)?”Czy korporacyjne tuzy podejmą skuteczną walkę z rakiem? Po co mieliby to robić? Przecież lepiej jest leczyć, aby leczyć, niż trwale wyleczyć. Pieniądze muszą się zgadzać. A jak to się ma do hasła wszystkich lekarzy: Primum non nocere (Po pierwsze nie szkodzić)?
Hubert Czerniak

Hubert Czerniak repeats that the fight against cancer should not be based on chemotherapy and cites the same finding: a 2.1% increase in the chance of surviving five years.

Henryk Różański

Henryk Różański lists mistletoe and Iscador for the pre- and postoperative period, an herbal mixture for changes in white blood cell counts, and milk thistle as a supplement to chemotherapy.

„Symptoms/period/therapy Pre- and postoperative period of primary treatment Mistletoe herb – Viscum; Mistelkraut Iscador – ampoules, administered subcutaneously. Changes in white blood cell levels, leukopenia Combination preparation: Baptisia – wild indigo (Färberhülsenwurzel); Thuja – arborvitae, tips (Lebensbaumspitzen); Echinacea – coneflower, root (Sonnenhutwurzel); mixture Supplementary treatment during chemotherapy Milk thistle seeds – Cardui mariae fructus (semen); (Mariendistelfrüchte) Silimarit – capsules”Objawy/okres/terapia okres przed- i pooperacyjny leczenia podstawowego ziele jemioły – Viscum; Mistelkraut Iscador – amp. podskórnie. Zmiany w poziomie białych ciałek krwi, depresja leukocytowa Preparat złożony: Baptisia – bratwa (Färberhülsenwurzel) Thuja – żywotnik, wierzchołki (Liebensbaumspitzen) Echinacea – jeżówka, korzeń (Sennenhutwurzel); mieszanka Leczenie uzupełniające przy chemioterapii Nasiona ostropestu – Cardui mariae fructus (semen); (Mariendistelfrüchte) Silimarit – kaps.
Henryk Różański

Henryk Różański lists eleuthero for convalescence and infections, ginseng for fatigue, St. John's wort for depression, and marshmallow for inflammation of the oral mucosa and dry mouth.

„Convalescence, accompanying infections Eleutherococcus – root; (Taigawurzel) Eleu-Kokk – coated tablets, 1 tablet 3 times a day General fatigue and exhaustion Panax ginseng, ginseng, root (radix); (Ginsengwurzel) Ardey-aktiv – lozenges; each lozenge contains 100 mg of dry ginseng extract 4:1, equivalent to 400 mg of ginseng root; 3 lozenges daily. Depression, discouragement St. John's wort herb, Hypericum (Johanniskraut) Laif 900, 1 tablet in the morning (each tablet contains 900 mg of St. John's wort extract 3–6:1) Cardiomyopathies caused by chemotherapy Hawthorn leaf with flower, Crataegus, Folium, Flos (Weißdornblätter mit Blüten) Crataegutt novo 450 mg; 1 tablet in the morning and 1 tablet in the evening; (contains 450 mg of dry extract) Inflammation of the oral mucosa, dry mouth Marshmallow root – Althaea officinalis; (Eibischwurzel)”rekonwalescencja, infekcje towarzyszące Eleutherococcus – korzeń; (Taigawurzel) Eleu-Kokk – draż. 3 razy dz. po 1 draż. ogólne zmęczenie i wyczerpanie Panax ginseng, żeń-szeń, korzeń (radix); (Ginsengwurzel) Ardey-aktiv – pastylki; w 1 pastylce jest 100 mg suchego ekstraktu z żeń-szenia 4:1, co odpowiada 400 mg korzenia żeń-szeń; 3 pastylki dziennie. depresja, zniechęcenie ziele dziurawca, Hypericum (Johanniskraut) Laif 900, 1 tabletka rano (w 1 tabletce jest 900 mg ekstraktu z ziela dziurawca 3-6:1) kardiomiopatie wywołane chemioterapią liść z kwiatem głogu Crataegus, Folium, Flos (Weißdornblätter mit Blüten) Crataegutt novo 450 mg; 1 tabletka rano i 1 tabletka wieczorem; (zawiera suchy ekstrakt 450 mg) zapalenie błony śluzowej jamy ustnej, suchość w ustach korzeń prawoślazu – Althaea officinalis; (Eibischwurzel)
Henryk Różański

Henryk Różański lists hawthorn for cardiomyopathies caused by chemotherapy.

„Depression, discouragement St. John's wort herb, Hypericum (Johanniskraut) Laif 900, 1 tablet in the morning (each tablet contains 900 mg of St. John's wort extract 3–6:1) Cardiomyopathies caused by chemotherapy Hawthorn leaf with flower, Crataegus, Folium, Flos (Weißdornblätter mit Blüten) Crataegutt novo 450 mg; 1 tablet in the morning and 1 tablet in the evening; (contains 450 mg of dry extract) Inflammation of the oral mucosa, dry mouth Marshmallow root – Althaea officinalis; (Eibischwurzel)”depresja, zniechęcenie ziele dziurawca, Hypericum (Johanniskraut) Laif 900, 1 tabletka rano (w 1 tabletce jest 900 mg ekstraktu z ziela dziurawca 3-6:1) kardiomiopatie wywołane chemioterapią liść z kwiatem głogu Crataegus, Folium, Flos (Weißdornblätter mit Blüten) Crataegutt novo 450 mg; 1 tabletka rano i 1 tabletka wieczorem; (zawiera suchy ekstrakt 450 mg) zapalenie błony śluzowej jamy ustnej, suchość w ustach korzeń prawoślazu – Althaea officinalis; (Eibischwurzel)
Hubert Czerniak

Hubert Czerniak claims that bacterial culture preparations help people get through various medical procedures, including chemotherapy and radiotherapy.

„These are bacterial culture preparations that help you survive even when you undergo various medical procedures, such as chemotherapy or radiotherapy. They are the only bacteria that survive and save us. After the explosion in Chernobyl, many people involved in the rescue operation died as a result of radiation sickness.”Są to preparaty kultur bakterii, które pomagają przeżyć, nawet gdy jesteście poddani różnym procedurom medycznym tj. chemioterapia czy radioterapia. To jedyne bakterie, które przeżywają i nas ratują. Po eksplozji w Czarnobylu wielu ludzi uczestniczących w akcji ratowniczej zmarło w efekcie choroby popromiennej.

What does scientific research from PubMed · Europe PMC say?

We selected 3 studies with the best, positive results. This is a selection, not a full review of all research.

Total number of studies on this topic in PubMed: 1 149 646.

Aim of the study: To update a systematic review and meta-analysis assessing the effect of neoadjuvant chemotherapy in the treatment of patients with invasive bladder cancer.

Results: The updated results are based on 11 trials and 3005 patients, comprising 98% of all patients from known eligible randomised controlled trials. We found a significant survival benefit associated with platinum-based combination chemotherapy (HR = 0.86, 95% CI 0.77-0.95, p = 0.003). This is equivalent to a 5% absolute improvement in survival at 5 years. There was also a significant disease-free survival benefit associated with platinum-based combination chemotherapy (HR = 0.78, 95% CI 0.71-0.86, p < 0.0001), equivalent to a 9% absolute improvement at 5 years. These results provide the best available evidence in support of the use of neoadjuvant platinum-based combination chemotherapy.

Money for the studygovernment, public institutions
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studycombined analysis of many studies (meta-analysis)
Participants3 005

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: For approximately a decade, chemotherapy has been shown to prolong life in patients with metastatic castration-resistant prostate cancer (mCRPC). Since that time, however, only two agents have proven to prolong life (docetaxel and cabazitaxel).

Results: For approximately a decade, chemotherapy has been shown to prolong life in patients with metastatic castration-resistant prostate cancer (mCRPC). Since that time, however, only two agents have proven to prolong life (docetaxel and cabazitaxel). However, in the last year, the addition of chemotherapy to primary hormonal therapy became a standard of care for high-volume castration-sensitive metastatic disease. Here I will review current prostate cancer chemotherapies, mechanisms of resistance to those therapies, and ongoing clinical studies of chemotherapy combinations and novel chemotherapeutics.

Chemotherapy in Prostate Cancer. · Curr Oncol Rep 2015
Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Genomic assays guide adjuvant treatment decisions in early-stage hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer, yet contemporary treatment patterns and outcomes among premenopausal women remain incompletely characterized, particularly as adjuvant CDK4/6 inhibitors enter routine use.

Results: Overall, 13,490 women (69.5%) received no adjuvant chemotherapy. Chemotherapy receipt rose with genomic risk and CDK4/6 inhibitor eligibility, while OncotypeDX testing was least frequent in the highest-risk groups. Adjuvant chemotherapy was independently associated with improved OS overall (adjusted HR 0.64, 95% CI 0.47-0.86). In RS-stratified analyses, the association was limited to RS 21-25 (aHR 0.24, 95% CI 0.08-0.68) and unknown RS (aHR 0.61, 95% CI 0.42-0.89). Adjuvant chemotherapy was associated with improved OS, mostly among RS 21-25 and a higher-risk unknown-RS group. Frequent absence of genomic testing among CDK4/6 inhibitor-eligible women highlights an opportunity to better integrate genomic and clinical-anatomic risk in treatment selection.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyobservation of people
Participants19 419

“Not stated” does not mean nobody paid — the database does not always record it.

What do orthomolecular medicine doctors write?

Orthomolecular Medicine News Service
„More than 40 years of clinical trials have shown that chemotherapy does not work for most tumors and that its use is counterproductive.” Chemotherapy drugs have come and gone; the five-year survival rate for cancer treated with chemotherapy has remained virtually unchanged for decades. Unfortunately, just over 2% of all cancers respond to chemotherapy. Specifically, one scientific review concluded, “The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA . . . chemotherapy only makes a minor contribution to cancer survival.””Chemotherapy has been shown by over 40 years of clinical trials not to work in the majority of tumors, and its use is counterproductive." Chemotherapy drugs have come and gone; the five year survival rate for cancer treated with chemo has remained virtually unchanged for decades. Unfortunately, just over 2% of all cancers respond to chemotherapy. Specifically, one scientific review concluded, "The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA . . . chemotherapy only makes a minor contribution to cancer survival.
Orthomolecular Medicine News Service
„Recent research has shown that while chemotherapy kills cancer, it also tends to enhance the spread of cancer throughout the body [22], and most cancer patients given chemotherapy eventually develop side effects or other organ failures. [22] Another common phenomenon is the off-label use of chemotherapeutic drugs for cancer patients, which, according to one study, often accounts for more than half of adult cancer treatments. [23] In another study, 33% to 65% of end-stage cancer patients were more likely to be given such off-label drugs. Eaton et al. reported that 82% of end-stage breast cancer patients take off-label chemotherapy.”Recent research has shown that while chemotherapy kills cancer, it also tends to enhance the spread of cancer throughout the body [22], and most cancer patients given chemotherapy eventually develop side effects or other organ failures. [22] Another common phenomenon is the off-label use of chemotherapeutic drugs for cancer patients, which according to one study often accounts for more than half of adult cancer treatments. [23] In another study, 33% to 65% of end-stage cancer patients were more likely to be given such off-label drugs. Eaton et al. reported that 82% of end-stage breast cancer patients take off-label chemotherapy.
Orthomolecular Medicine News Service
„It suggests that vitamin C sensitizes cancer cells to chemotherapy, potentially reducing tumor progression and improving patient outcomes. IHR Magazine. “Effectiveness of Intravenous Vitamin C in Combination with Conventional Chemotherapy in Cancer Treatment.” It refers to studies showing that IVC can improve tumor regression, survival rates, and overall quality of life, especially when used in combination with standard cancer treatments. Journal of Experimental & Clinical Cancer Research. “High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.” BioMed Central.”It suggests that vitamin C sensitizes cancer cells to chemotherapy, potentially reducing tumor progression and improving patient outcomes. IHR Magazine. "Effectiveness of Intravenous Vitamin C in Combination with Conventional Chemotherapy in Cancer Treatment." It refers to studies showing that IVC can improve tumor regression, survival rates, and overall quality of life, especially when used in combination with standard cancer treatments. Journal of Experimental & Clinical Cancer Research. "High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer." BioMed Central.

Sources (10)

Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.